Primary causes of death
. | Tacrolimus (N = 90) N (%) . | CSP (N = 90) N (%) . |
---|---|---|
GVHD | 3 (3) | 12 (13) |
Graft failure | 3 (3) | 6 (6) |
Regimen-related toxicity | 9 (10) | 8 (9) |
Interstitial pneumonia | 1 (1) | 0 |
Relapse | 11 (12) | 7 (8) |
Infection8-150 | 12 (13) | 8 (9) |
Viral | 2 (2) | 1 (1) |
Bacterial | 3 (3) | 3 (3) |
Fungal | 6 (6) | 4 (4) |
Pneumocystis carinii | 1 (1) | |
Other | 2 (2) | 4 (4) |
Total | 41 (46) | 45 (50) |
. | Tacrolimus (N = 90) N (%) . | CSP (N = 90) N (%) . |
---|---|---|
GVHD | 3 (3) | 12 (13) |
Graft failure | 3 (3) | 6 (6) |
Regimen-related toxicity | 9 (10) | 8 (9) |
Interstitial pneumonia | 1 (1) | 0 |
Relapse | 11 (12) | 7 (8) |
Infection8-150 | 12 (13) | 8 (9) |
Viral | 2 (2) | 1 (1) |
Bacterial | 3 (3) | 3 (3) |
Fungal | 6 (6) | 4 (4) |
Pneumocystis carinii | 1 (1) | |
Other | 2 (2) | 4 (4) |
Total | 41 (46) | 45 (50) |
Two patients with fungus infection in the tacrolimus group also had concomitant viral infections; 2 patients with fungus infection in the CSP group also had concomitant bacterial infections.